Table 3 Comparison of DRPs pre- and post the implementation of MTM
Pre MTM | Post MTM | ||
|---|---|---|---|
No. of events (Percentage out of total number of DRP) | p-value | ||
Untreated indication | 56 (4.5%) | 47 (5.91%) | 0.43 |
Improper drug selection | 22 (1.77%) | 14 (1.76%) | 0.14 |
Subtherapeutic dose | 27 (2.17%) | 9 (1.13%) | 0.001* |
Failure to receive drug | 24 (1.93%) | 7 (0.88%) | 0.004* |
Overdose | 39 (3.13%) | 16 (2.02%) | 0.002* |
Adverse effects | 1008 (80.96%) | 682 (85.89%) | <0.001* |
Drug interaction | 13 (1.04%) | 0 (0%) | 0.001* |
Drug without indication | 20 (1.61%) | 10 (1.26%) | 0.07 |
Mode of administration (Timing) | 18 (1.45%) | 9 (1.13%) | 0.05 |
Duplicate therapy | 18 (1.45%) | 0 (0%) | 0.001* |
Total Number of drug related problems Mean± SD (DRPs/patient) ** | (1245) 11.97±4.65 | (794) 7.63±3.85 | <0.001* |